The Food and Drug Administration (FDA) of the Republic of the Philippines has registered the Sputnik V vaccine, according to the Russian Direct Investment Fund (RDIF).
Vaccine registration was carried out as part of an accelerated procedure (emergency use authorization, EUA). Thus, Sputnik V is approved in 52 countries with a total population of over 1.4 billion people. In terms of the number of approvals received by state regulators, Sputnik V ranks second in the world.
“The Philippines was one of the first countries to express interest in the Sputnik V vaccine since its registration in Russia. After a thorough study and examination of the data provided, Sputnik V is now officially registered in the Republic and will become one of the leading tools to fight the coronavirus spreading. The Philippines is one of the most populated countries in Southeast Asia, and the diversification of the national vaccine portfolio due to the inclusion of the Sputnik V drug opens up access to one of the best vaccines that already saves lives around the world, “said Kirill Dmitriev, RDIF CEO.
Currently, the use of the Sputnik V vaccine has also been approved in Russia, Belarus, Argentina, Bolivia, Serbia, Algeria, Palestine, Venezuela, Paraguay, Turkmenistan, Hungary, the UAE, Iran, the Republic of Guinea, Tunisia, Armenia, Mexico, Nicaragua, the Republika Srpska (entity of Bosnia and Herzegovina), Lebanon, Myanmar, Pakistan, Mongolia, Bahrain, Montenegro, Saint Vincent and the Grenadines, Kazakhstan, Uzbekistan, Gabon, San Marino, Ghana, Syria, Kyrgyzstan, Guyana, Egypt, Honduras, Guatemala, Moldova, Slovakia, Angola, Djibouti, Republic of the Congo, Sri Lanka, Laos, Iraq, North Macedonia, Kenya, Morocco, Jordan, Namibia and Azerbaijan.